Cited by 156Malaria Research and ControlGlobal Maternal and Child HealthPregnancy and Medication Impact

Intermittent treatment to prevent pregnancy malaria does not confer benefit in an area of widespread drug resistance

Open access
Harrington, W. E., Mutabingwa, T. K., Kabyemela, E., Fried, M., Duffy, P. E.·2011·Clinical Infectious Diseases

Abstract

BACKGROUND: Millions of African women receive sulfadoxine-pyrimethamine (SP) as intermittent preventive treatment during pregnancy (IPTp) to avoid poor outcomes that result from malaria. However, parasites resistant to SP are widespread in parts of Africa, and IPTp may perversely exacerbate placental infections that contain SP-resistant parasites. METHODS: The study used a cross-sectional design. We determined IPTp use in a delivery cohort of 880 pregnant women in Muheza, Tanzania, by report and by plasma sulfa measurements, and we examined its effects on maternal and fetal delivery outcomes. RESULTS: In the overall cohort, IPTp was not associated with decreased odds of placental malaria or with increased mean maternal hemoglobin or mean birth weight. Unexpectedly, IPTp was associated with decreased cord hemoglobin level and increased risk of fetal anemia, which may be related to in utero SP exposure. CONCLUSIONS: IPTp does not improve overall pregnancy outcomes in Muheza, Tanzania, where SP-resistant parasites predominate and may increase the odds of fetal anemia. As parasite resistance increases in a community, the overall effect of IPTp may transition from net benefit to neutral or net harm.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/cid/cir376

Cites

31 of 31 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Cites

Flagged first, then by citations

Research works printed but not linked: 1

  1. Trenque T, Marx C, Quereux C, et al. Human maternofoetal distribution of pyrimethamine-sulphadoxine. Br J Clin Pharmacol 1998; 45:179-80.

Cited by

Sorted by citations

Authors
Harrington, W. E., Mutabingwa, T. K., Kabyemela, E., Fried, M., & Duffy, P. E.
Affiliations
Center for Infectious Disease Research (US)
Venue
Clinical Infectious Diseases
Published
2011-07-11
Volume
53
Issue
3
Pages
224-230
ISSN
  • 1058-4838 (ISSN-L)
  • 1537-6591
OpenAlex
W2141917084
Cited by
156
References
31
Citations by year
2026: 2 · 2025: 6 · 2023: 12 · 2022: 10 · 2021: 13 · 2020: 14 · 2019: 2 · 2018: 14 · 2017: 7 · 2016: 5 · 2015: 24 · 2014: 14 · 2013: 14 · 2012: 15
FWCI
14.78
Type
journal article
Language
en
Open access
Locations
  • Clinical Infectious Diseases (publishedVersion)
  • PubMed Central (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • Foundation for the National Institutes of Health
  • Bill and Melinda Gates Foundation (29202)
  • National Institutes of Health (7f30hl096298-03)
  • National Heart, Lung, and Blood Institute (F30 HL096298, 1F30HL096298)
  • National Institute of Allergy and Infectious Diseases (R01AI052059, R01AI52059)
  • Fogarty International Center (D43TW005509)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Malaria Research and Control
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Global Maternal and Child Health
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Pregnancy and Medication Impact
Keywords
intermittent preventive treatment in pregnancy, sulfadoxine-pyrimethamine, antimalarial drug resistance, placental malaria, fetal anemia, cord blood hemoglobin, birth weight, maternal hemoglobin, pregnancy outcomes
MeSH terms
Adult, Antimalarials, Cross-Sectional Studies, Drug Combinations, Drug Resistance, Female, Humans, Infant, Infant, Newborn, Malaria, Male, Plasmodium, Pregnancy, Pregnancy Complications, Infectious, Pyrimethamine, Sulfadoxine, Tanzania, Treatment Outcome, Chemoprevention

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review